Not Ready for Prime Time: Intermittent versus Partial REBOA for Prolonged Hemorrhage Control In a Highly Lethal Porcine Injury Model.

Partial resuscitative endovascular balloon occlusion of the aorta (pREBOA) and intermittent-REBOA (iREBOA) are techniques to extend the therapeutic duration of REBOA by balloon titration for distal flow or cyclical balloon inflation/deflation to allow transient distal flow, respectively. We hypothesized that manually-titrated pREBOA would reduce blood losses and ischemic burden when compared to iREBOA.Following 20% blood volume controlled hemorrhage, 10 anesthetized pigs underwent uncontrolled hemorrhage from the right iliac artery and vein. Once in hemorrhagic shock, animals underwent 15 minutes of complete Zone 1 REBOA followed by 75 minutes of either pREBOA or iREBOA (N=5/group). After 90 minutes, definitive hemorrhage control was obtained, animals were resuscitated with the remaining collected blood, and then received 2 hours of critical care.There were no differences in mortality. Animals randomized to iREBOA spent a larger portion of the time at full occlusion when compared to pREBOA (median [IQR]; 70 minutes [70, 80] versus 20 minutes [20, 40] respectively; p=0.008). While the average blood pressure during the intervention period was equivalent between groups, this was offset by large fluctuations in blood pressure and significantly more rescue occlusions for hypotension with iREBOA. Despite lower maximum aortic flow rates, the pREBOA group tolerated a greater total amount of distal aortic flow during the intervention period (median [IQR]; 20.9 L [20.1-23.0] vs 9.8 L [6.8-10.3]; p=0.03) with equivalent abdominal blood losses. Final plasma lactate and creatinine concentrations were equivalent, although iREBOA animals had increased duodenal edema on histology.Compared to iREBOA, pREBOA reduced the time spent at full occlusion and the number of precipitous drops in proximal MAP while delivering more distal aortic flow but not increasing total blood loss in this highly lethal injury model. Neither technique demonstrated a survival benefit. Further refinement of these techniques is necessary before clinical guidelines are issued.III STUDY TYPE: Therapeutic.